IBRX
ImmunityBio, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:58 PM EDT
10.29USD+10.884%(+1.01)31,251,554
Pre-marketOct 2, 2026 9:29:30 AM EDT
9.36USD+0.862%(+0.08)
After-hoursOct 2, 2026 4:59:30 PM EDT
10.39USD+0.972%(+0.10)
Loading…
Loading…
10.88B
Healthcare
Biotechnology
HQ
San Diego, CA, USA
703
Previous Close
$9.28
Beta
1.64
52-Week High
$12.43 2026-02-25
52-Week Low
$1.95 2025-12-31
SMA 50
$8.00
SMA 200
$7.21
Avg. Vol 10D
15.18M
Avg. Vol 30D
11.33M
Avg. Vol 90D
11.12M
Relative Vol
2.76
1.06B
113.84M
10.74%
125,408,192
110.16%
15.86
50%/50%
52.26%
39.70%
0.5800%
1,400,000
3,560
147,554
2,098,100
Nov 3, 2026 (29d)
Sep 22, 2026
Sep 20, 2026
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.
IBRX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.52 | 2026-09-28 | +20.48% | 5.159 |
| 1M | 8.08 | 2026-09-04 | +27.04% | 2.564 |
| 3M | 8.91 | 2026-07-06 | +15.21% | 1.822 |
| 6M | 7.08 | 2026-04-06 | +44.99% | 1.451 |
| 1Y | 2.54 | 2025-10-03 | +304.13% | 1.635 |
| 2Y | 3.43 | 2024-10-04 | +199.27% | — |
| 5Y | 9.84 | 2021-10-04 | +4.32% | 2.107 |
IBRX Stock Summary
ImmunityBio, Inc. Common Stock (NASDAQ:IBRX) stock price today is $10.27, and today's volume is 31,251,554. IBRX is up 10.614% today. The 30 day average volume is 11.33M. IBRX market cap is $10.88B with 1.06B shares outstanding.